Vipergen Publishes First Technology for Screening DNA-Encoded Small-Molecule Libraries (DELs) Inside Living Cells

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): PR Newswire
  • Source:
    PR Newswire US. 02/17/2021.
  • Additional Information
    • Alternate Title:
      VIPERGEN-CBTE-DELs
    • Subject Terms:
      Denmark
    • Abstract:
      COPENHAGEN, Denmark, Feb. 17, 2021 /PRNewswire/ -- Vipergen ApS announced today a published study describing a powerful new drug discovery approach that enables, for the first time, screening DNA-encoded small-molecule libraries (DELs) inside living cells. The study, published in the peer-reviewed Journal of the American Chemical Society, highlights the potential of Vipergen's Cellular Binder Trap Enrichment® (cBTE) technology to significantly expand the ability to discover novel small molecules, including against difficult-to-drug targets, and reduce attrition rates in drug discovery. Vipergen is offering its cBTE DNA-encoded library drug discovery platform as a service to biotechnology and pharmaceutical company partners to accelerate and improve their drug discovery processes. [ABSTRACT FROM PUBLISHER]